Sorbonne Paris Cité, Université Paris7 Denis Diderot, Paris, France; CART, INSERM UMR965, Hôpital Lariboisière, F-75010, Paris, France.
Sorbonne Paris Cité, Université Paris7 Denis Diderot, Paris, France; CART, INSERM UMR965, Hôpital Lariboisière, F-75010, Paris, France; AP-HP, Hôpital Lariboisière, Physiologie Clinique - Explorations Fonctionnelles, F-75010, Paris, France.
Eur J Surg Oncol. 2019 Sep;45(9):1727-1733. doi: 10.1016/j.ejso.2019.03.001. Epub 2019 Mar 6.
After incomplete cytoreductive surgery (CRS), the assessment of pseudomyxoma peritonei (PMP) progression remains challenging. The objective was to assess the efficacy of wall shear stress (WSS) measured in superior mesenteric artery (SMA) to predict PMP progression in the postoperative setting to propose additional treatments.
In a prospective study, 52 patients with PMP had Doppler-ultrasound examination of the SMA with WSS calculation within one year after CRS with a mean follow-up of 43.3 ± 18.3 months. Patients were categorized according to the completeness of CRS and clinical outcome: Group-1 (n = 19): complete CRS and no recurrence, group-2 (n = 20): incomplete CRS with slowly progressive disease (alive at 2 years without severe clinical symptoms), group-3 (n = 13): incomplete CRS and severe clinical symptoms or dead within two years. Results of WSS were compared between groups and to 24 healthy subjects.
WSS measured in the SMA was superior in Group-3 (19.6 ± 8.2 dynes/cm) than in Group-2 (9.2 ± 1.8 dynes/cm, p = 1.10), Group-1 (10.4 ± 2.8 dynes/cm, p = 8.10), and healthy patients (8.7 ± 2.8 dynes/cm, p = 9.10). One year after surgery, among patients with incomplete CRS a cut-off value of 12.1dynes/cm allowed distinguishing patients without from those with severe disease progression with a sensitivity of 100% and a specificity of 100% (p < 1.10) AUC = 1.000 [95%CI: 0.897-1.000].
Post-operative assessment of the WSS in the SMA in patients with incomplete CRS for PMP should be considered as biomarker of tumor progression in the postoperative setting. Therefore, WSS could be useful to target patients needing adjuvant systemic chemotherapy one year after CRS.
在不完全细胞减灭术后(CRS),评估假性黏液瘤腹膜(PMP)进展仍然具有挑战性。本研究的目的是评估肠系膜上动脉(SMA)壁切应力(WSS)测量在预测术后 PMP 进展方面的有效性,以提出额外的治疗方法。
在一项前瞻性研究中,52 例 PMP 患者在 CRS 后一年内接受了 SMA 的多普勒超声检查和 WSS 计算,平均随访时间为 43.3±18.3 个月。根据 CRS 的完整性和临床结果将患者分为三组:组 1(n=19):完全 CRS 且无复发;组 2(n=20):不完全 CRS 且疾病进展缓慢(两年内无严重临床症状且存活);组 3(n=13):不完全 CRS 且两年内出现严重临床症状或死亡。比较了各组之间以及与 24 名健康受试者之间的 WSS 结果。
组 3(19.6±8.2 dynes/cm)的 SMA 中测量的 WSS 明显高于组 2(9.2±1.8 dynes/cm,p=1.10)、组 1(10.4±2.8 dynes/cm,p=8.10)和健康患者(8.7±2.8 dynes/cm,p=9.10)。在不完全 CRS 的患者中,手术后一年,12.1 dynes/cm 的截断值可区分无严重疾病进展的患者和有严重疾病进展的患者,其敏感性为 100%,特异性为 100%(p<1.10),AUC=1.000 [95%CI:0.897-1.000]。
对于接受不完全 CRS 治疗的 PMP 患者,术后 SMA 中 WSS 的评估应被视为术后肿瘤进展的生物标志物。因此,WSS 可用于在 CRS 后一年靶向需要辅助全身化疗的患者。